Oral antiplatelet therapy for acute ischaemic stroke (Review)

THERAPEUTIC CLASS

Oral antiplatelet therapy for acute ischaemic stroke (Review)

Sandercock PAG - Personal Name;

In people with acute ischaemic stroke, platelets become activated and can cause blood clots to form and block an artery in the brain,
resulting in damage to part of the brain. Such damage gives rise to the symptoms of stroke. Antiplatelet therapy might reduce the volume
of brain damaged by ischaemia and also reduce the risk of early recurrent ischaemic stroke, thereby reducing the risk of early death and
improving long-term outcomes in survivors. However, antiplatelet therapy might also increase the risk of fatal or disabling intracranial
haemorrhage.

Availability

Location name is not set Location name is not set

REQJ4499

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Cardiovascular & Hematopoeiteic System
Specific Detail Info: Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD000029.
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment